These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

459 related items for PubMed ID: 16842459

  • 1. The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort.
    Ho GT, Chiam P, Drummond H, Loane J, Arnott ID, Satsangi J.
    Aliment Pharmacol Ther; 2006 Jul 15; 24(2):319-30. PubMed ID: 16842459
    [Abstract] [Full Text] [Related]

  • 2. Predictors of corticosteroid-dependent and corticosteroid-refractory inflammatory bowel disease: analysis of a Chinese cohort study.
    Chow DK, Sung JJ, Tsoi KK, Wong VW, Wu JC, Leong RW, Chan FK.
    Aliment Pharmacol Ther; 2009 Apr 15; 29(8):843-54. PubMed ID: 19154567
    [Abstract] [Full Text] [Related]

  • 3. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis.
    Bernstein CN, Seeger LL, Sayre JW, Anton PA, Artinian L, Shanahan F.
    J Bone Miner Res; 1995 Feb 15; 10(2):250-6. PubMed ID: 7754804
    [Abstract] [Full Text] [Related]

  • 4. A population-based study of the frequency of corticosteroid resistance and dependence in pediatric patients with Crohn's disease and ulcerative colitis.
    Tung J, Loftus EV, Freese DK, El-Youssef M, Zinsmeister AR, Melton LJ, Harmsen WS, Sandborn WJ, Faubion WA.
    Inflamm Bowel Dis; 2006 Dec 15; 12(12):1093-100. PubMed ID: 17119382
    [Abstract] [Full Text] [Related]

  • 5. A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration.
    Nathan DM, Iser JH, Gibson PR.
    J Gastroenterol Hepatol; 2008 Jun 15; 23(6):954-8. PubMed ID: 17559377
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Corticosteroid therapy in the age of infliximab: acute and 1-year outcomes in newly diagnosed children with Crohn's disease.
    Markowitz J, Hyams J, Mack D, Leleiko N, Evans J, Kugathasan S, Pfefferkorn M, Mezoff A, Rosh J, Tolia V, Otley A, Griffiths A, Moyer MS, Oliva-Hemker M, Wyllie R, Rothbaum R, Bousvaros A, Del Rosario JF, Hale S, Lerer T, Pediatric IBD Collaborative Research Group.
    Clin Gastroenterol Hepatol; 2006 Sep 15; 4(9):1124-9. PubMed ID: 16861053
    [Abstract] [Full Text] [Related]

  • 9. [Compared azathioprine efficacy in ulcerative colitis and in Crohn's disease].
    Kull E, Beau P.
    Gastroenterol Clin Biol; 2002 Apr 15; 26(4):367-71. PubMed ID: 12070412
    [Abstract] [Full Text] [Related]

  • 10. Current status of drug therapy for inflammatory bowel disease.
    Peppercorn MA.
    Compr Ther; 1985 Dec 15; 11(12):14-9. PubMed ID: 2866866
    [Abstract] [Full Text] [Related]

  • 11. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
    Roblin X, Serre-Debeauvais F, Phelip JM, Faucheron JL, Hardy G, Chartier A, Helluwaert F, Bessard G, Bonaz B.
    Aliment Pharmacol Ther; 2005 Apr 01; 21(7):829-39. PubMed ID: 15801918
    [Abstract] [Full Text] [Related]

  • 12. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease.
    Folwaczny C, Wiebecke B, Loeschke K.
    Am J Gastroenterol; 1999 Jun 01; 94(6):1551-5. PubMed ID: 10364024
    [Abstract] [Full Text] [Related]

  • 13. Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohn's disease, while smoking decreases the risk of colectomy in ulcerative colitis.
    Szamosi T, Banai J, Lakatos L, Czegledi Z, David G, Zsigmond F, Pandur T, Erdelyi Z, Gemela O, Papp M, Papp J, Lakatos PL.
    Eur J Gastroenterol Hepatol; 2010 Jul 01; 22(7):872-9. PubMed ID: 19648821
    [Abstract] [Full Text] [Related]

  • 14. Immunomodulators are associated with a lower risk of first surgery among patients with non-penetrating non-stricturing Crohn's disease.
    Picco MF, Zubiaurre I, Adluni M, Cangemi JR, Shelton D.
    Am J Gastroenterol; 2009 Nov 01; 104(11):2754-9. PubMed ID: 19584832
    [Abstract] [Full Text] [Related]

  • 15. Are patients with inflammatory bowel disease receiving optimal care?
    Reddy SI, Friedman S, Telford JJ, Strate L, Ookubo R, Banks PA.
    Am J Gastroenterol; 2005 Jun 01; 100(6):1357-61. PubMed ID: 15929770
    [Abstract] [Full Text] [Related]

  • 16. The insulin-like growth factor (IGF)-system in active ulcerative colitis and Crohn's disease: relations to disease activity and corticosteroid treatment.
    Eivindson M, Grønbaek H, Flyvbjerg A, Frystyk J, Zimmermann-Nielsen E, Dahlerup JF.
    Growth Horm IGF Res; 2007 Feb 01; 17(1):33-40. PubMed ID: 17126585
    [Abstract] [Full Text] [Related]

  • 17. Intravenous cyclosporine for inflammatory bowel disease--safe and effective.
    Chermesh I, Tamir A, Lachter J, Eliakim R.
    Hepatogastroenterology; 2007 Feb 01; 54(79):2003-6. PubMed ID: 18251148
    [Abstract] [Full Text] [Related]

  • 18. Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corticosteroids on fetal outcome.
    Mogadam M, Dobbins WO, Korelitz BI, Ahmed SW.
    Gastroenterology; 1981 Jan 01; 80(1):72-6. PubMed ID: 6108894
    [Abstract] [Full Text] [Related]

  • 19. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study.
    Faubion WA, Loftus EV, Harmsen WS, Zinsmeister AR, Sandborn WJ.
    Gastroenterology; 2001 Aug 01; 121(2):255-60. PubMed ID: 11487534
    [Abstract] [Full Text] [Related]

  • 20. Paediatric inflammatory bowel disease in New Zealand.
    Yap J, Wesley A, Mouat S, Chin S.
    N Z Med J; 2008 Oct 03; 121(1283):19-34. PubMed ID: 18841182
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.